Skip to content
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will......
Vaccine-maker Novavax (NVAX) is a $6.5 billion company with only $18 million in trailing sales and no profits whatsoever -- but "thanks" to the novel coronavirus, that could soon change. Indeed, in one analyst's view, as little as a year from now, vaccinating patients against COVID-19 could turn out to be a billion-dollar business for Novavax -- or more.But first, the bad news.In a note published Thursday, H.C. Wainwright analyst Vernon Bernardino cites "mathematical models we reviewed online" to argue that contrary to what optimists have been saying, "herd immunity" to infection with coronavirus may not be a viable option for ending the pandemic -- at least not in the short term.As Bernardino points out, coronavirus continues raging around the globe. The latest data show 13.2 million infections have been reported globally, and those infections are growing at the rate of 1.4% per day. Part of the reason that coronavirus continues...
Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Equity Income Fund posted a return of 18.29% for the quarter, underperforming its benchmark, the S&P 500 Index which returned 20.55% in the same quarter. You should check out Brown Advisory’s top 5 stock picks for investors […]...
PORT ST. LUCIE, Fla., July 17, 2020 /CNW/ - Trulieve Cannabis Corp. (CSE: TRUL) & (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company based in the United States, announced today the opening of its latest storefront. Opening on Saturday, July 18th, the Port St. Lucie location will be the Company's 52nd dispensary in its home state of Florida and 54th nationwide....
Gold has moved to an all-time high, and many gold miners have rallied in response. But, somewhat quietly, silver stocks have gained as well.A move higher in the underlying commodity no doubt has helped. Indeed, save for a brief move last year, silver trades at its highest level in almost four years. And there's a case that silver stocks should continue to rally and potentially outperform its more valuable and more widely-held counterpart.To be sure, the setup for gold at the moment seems almost perfect. The coronavirus pandemic adds risk worldwide, and can lead investors to the safety of the yellow metal. A ballooning federal deficit, along with interventions by the Federal Reserve, raise the specter of inflation -- another bullish catalyst for gold.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBut silver and silver stocks, can benefit for similar reasons. Indeed, they have: silver has rallied some 65% from...
Andrew Sculley became the CEO of eMagin Corporation (NYSEMKT:EMAN) in 2008, and we think it's a good time to look at......
